Christoph E. Heilig

2.7k total citations
32 papers, 547 citations indexed

About

Christoph E. Heilig is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Christoph E. Heilig has authored 32 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Pulmonary and Respiratory Medicine and 11 papers in Oncology. Recurrent topics in Christoph E. Heilig's work include Sarcoma Diagnosis and Treatment (10 papers), Cancer Genomics and Diagnostics (10 papers) and Acute Myeloid Leukemia Research (5 papers). Christoph E. Heilig is often cited by papers focused on Sarcoma Diagnosis and Treatment (10 papers), Cancer Genomics and Diagnostics (10 papers) and Acute Myeloid Leukemia Research (5 papers). Christoph E. Heilig collaborates with scholars based in Germany, United States and United Kingdom. Christoph E. Heilig's co-authors include Anthony D. Ho, Alwin Krämer, Bernhard Heilig, Jessica Wohlgemuth, Anna Jauch, Johannes W.G. Janssen, Stefan Fröhling, Tilmann Bochtler, Gerhard Ehninger and Albrecht Stenzinger and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Cell Biology.

In The Last Decade

Christoph E. Heilig

30 papers receiving 536 citations

Peers

Countries citing papers authored by Christoph E. Heilig

Since Specialization

Citations

This map shows the geographic impact of Christoph E. Heilig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph E. Heilig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph E. Heilig more than expected).

Fields of papers citing papers by Christoph E. Heilig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christoph E. Heilig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph E. Heilig. The network helps show where Christoph E. Heilig may publish in the future.

Co-authorship network of co-authors of Christoph E. Heilig

This figure shows the co-authorship network connecting the top 25 collaborators of Christoph E. Heilig. A scholar is included among the top collaborators of Christoph E. Heilig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoph E. Heilig. Christoph E. Heilig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	⁹⁰Y-FAPI-46 Theranostics Leads to Near-Complete Metabolic Response in 3 Patients with Solitary Fibrous Tumors 2025 ·Journal of Nuclear Medicine ·(unknown), Christoph E. Heilig, Eva Wardelmann, (unknown), Kim M. Pabst, (unknown), (unknown), Pedro Fragoso Costa, Michael Nader, (unknown), Martin Schüler, Sebastian Bauer, Jens T. Siveke, (unknown), Simon Kreutzfeldt, Stefan Fröhling, (unknown), Ken Herrmann, Wolfgang P. Fendler, Rainer Hamacher	2
2	198P Inavolisib in cancers with activating PIK3CA mutations: Results from the CRAFT trial 2024 ·Annals of Oncology ·Christoph E. Heilig, (unknown), Alexander Desuki, Thomas Kindler, Barbara Deschler-Baier, (unknown), Nikolas von Bubnoff, (unknown), Damian Rieke, (unknown), (unknown), Simon Kreutzfeldt, Peter Horak, Karen Steindorf, Axel Benner, Daniel Hübschmann, Nina Schweigert, (unknown), Stefan Fröhling, Richard F. Schlenk	1
3	131O A composite biomarker for evaluation of homologous recombination repair deficiency in a pan-cancer cohort 2023 ·Annals of Oncology ·(unknown), Michael Rheinnecker, Barbara Hutter, Martina Fröhlich, Christoph E. Heilig, Nagarajan Paramasivam, Małgorzata Oleś, Claudia R. Ball, Hanno Glimm, Mario Hlevnjak, Marc Zapatka, Peter Lichter, Stefan Fröhling, Richard F. Schlenk, Daniel Hübschmann	1
4	1940P Deep molecular profiling of advanced synovial sarcoma as a basis for interventional clinical trials 2023 ·Annals of Oncology ·Richard F. Schlenk, Małgorzata Oleś, Sebastian Bauer, Thomas Kindler, Frederick Klauschen, Christian Brandts, Damian Rieke, (unknown), Melanie Börries, Christoph Heining, Peter Horak, Michael Bitzer, Uta Dirksen, Monika Sparber‐Sauer, (unknown), Simon Kreutzfeldt, Hanno Glimm, Daniel Hübschmann, Christoph E. Heilig, Stefan Fröhling	0
5	2318P Value of broad molecular profiling for cancer diagnosis 2023 ·Annals of Oncology ·(unknown), Christoph E. Heilig, (unknown), Jennifer Hüllein, Mandeep Singh, Sebastian Bauer, Thomas Kindler, Frederick Klauschen, Christian Brandts, Damian Rieke, (unknown), Melanie Börries, Simon Kreutzfeldt, Peter Horak, Daniel Hübschmann, Daniel B. Lipka, Hanno Glimm, Wolfgang Hartmann, Stefan Fröhling	1
6	1936P Targeted therapy of desmoplastic small round cell tumor guided by multilayered molecular profiling 2023 ·Annals of Oncology ·Marcus Renner, Małgorzata Oleś, Nagarajan Paramasivam, Achim Schneider, Christoph E. Heilig, (unknown), (unknown), Andreas Möck, Daniel B. Lipka, Sebastian Bauer, Thomas Kindler, Christian Brandts, Ulrich Keilholz, Melanie Boerries, Bernhard Küster, Daniel Hübschmann, Matthias Schlesner, Hanno Glimm, Richard F. Schlenk, Stefan Fröhling	1
7	1490MO CDK4/6 inhibition in locally advanced/metastatic chordoma (NCT PMO-1601) 2022 ·Annals of Oncology ·(unknown), Christoph E. Heilig, Rainer Hamacher, Sebastian Bauer, (unknown), Verena I. Gaidzik, Peter Horak, (unknown), (unknown), (unknown), Angelika Freitag, (unknown), (unknown), (unknown), (unknown), Stefan Fröhling, Richard F. Schlenk	4
8	487P Randomized phase II study of trabectedin/olaparib compared to physician’s choice in subjects with previously treated advanced or recurrent solid tumors harboring DNA repair deficiencies 2022 ·Annals of Oncology ·Christoph E. Heilig, (unknown), (unknown), Susan Richter, Jens T. Siveke, Stephan N. Wagner, H-G. Kopp, Thomas Kindler, (unknown), Alexander Golf, (unknown), Axel Benner, (unknown), Angelika Freitag, (unknown), (unknown), Daniel Hübschmann, Stefan Fröhling, Richard F. Schlenk	0
9	Intimal sarcomas and undifferentiated cardiac sarcomas carry mutually exclusive MDM2, MDM4, and CDK6 amplifications and share a common DNA methylation signature 2021 ·Modern Pathology ·Christian Koelsche, Jamal Benhamida, F. Kommoss, Damian Stichel, David Jones, Stefan M. Pfister, Christoph E. Heilig, Stefan Fröhling, Albrecht Stenzinger, Rolf Buslei, Thomas Mentzel, Daniel Baumhoer, Marc Ladanyi, Cristina R. Antonescu, Uta Flucke, Joost van Gorp, Beata Bode‐Lesniewska, Andreas von Deimling, Gunhild Mechtersheimer	24
10	Detection of Structural Variants in Circulating Cell-Free DNA from Sarcoma Patients Using Next Generation Sequencing 2020 ·Cancers ·(unknown), (unknown), Katja Beck, (unknown), Louise Harewood, Peter Stewart, Daniel Hübschmann, Albrecht Stenzinger, Hanno Glimm, Christoph E. Heilig, Stefan Fröhling, David González	13
11	Endometrial stromal sarcomas with BCOR‐rearrangement harbor MDM2 amplifications 2020 ·The Journal of Pathology Clinical Research ·F. Kommoss, Kenneth Tou En Chang, Damian Stichel, Ana Banito, David Jones, Christoph E. Heilig, Stefan Fröhling, Felix Sahm, Albrecht Stenzinger, Wolfgang Hartmann, Gunhild Mechtersheimer, Hans‐Peter Sinn, Dietmar Schmidt, (unknown), (unknown), Andreas von Deimling, Christian Koelsche	36
12	Haematopoietic stem cell transplantation in adult soft-tissue sarcoma: an analysis from the European Society for Blood and Marrow Transplantation 2020 ·ESMO Open ·Christoph E. Heilig, Manuela Badoglio, Myriam Labopin, Stefan Fröhling, Simona Secondino, (unknown), Emmanuelle Nicolas‐Virelizier, Didier Blaise, Clément Korenbaum, Armando Santoro, Mareike Verbeek, William Krüger, Salvatore Siena, Jakob Passweg, Massimo Di Nicola, J. Rifón, Peter Dreger, Ulrike Koehl, Christian Chabannon, Paolo Pedrazzoli	2
13	Intracellular vorinostat accumulation and its relationship to histone deacetylase activity in soft tissue sarcoma patients 2017 ·Cancer Chemotherapy and Pharmacology ·Jürgen Burhenne, Lu Liu, Christoph E. Heilig, Andreas D. Meid, (unknown), Thomas Schmitt, Bernd Kasper, Walter E. Haefeli, Gerd Mikus, Gerlinde Egerer	6
14	Vorinostat in refractory soft tissue sarcomas – Results of a multi-centre phase II trial of the German Soft Tissue Sarcoma and Bone Tumour Working Group (AIO) 2016 ·European Journal of Cancer ·Thomas Schmitt, Regine Mayer‐Steinacker, Frank Mayer, Viktor Grünwald, J. Schütte, Jörg T. Hartmann, Bernd Kasper, Johannes Hüsing, Jacek Hajda, (unknown), Gunhild Mechtersheimer, Gerd Mikus, Jürgen Burhenne, Lorenz Lehmann, Christoph E. Heilig, Anthony D. Ho, Gerlinde Egerer	32
15	Bone Marrow Harvesting of Allogeneic Donors in an Outpatient Setting: A Single-Center Experience 2015 ·Biology of Blood and Marrow Transplantation ·Katharina Lisenko, (unknown), Thomas Brückner, Petra Pavel, Christoph E. Heilig, Anita Schmitt, Joe Puthenparambil, (unknown), Anthony D. Ho, Peter Dreger, Mathias Witzens‐Harig, Patrick Wuchter	5
16	Pretreatment d-2-hydroxyglutarate serum levels negatively impact on outcome in IDH1-mutated acute myeloid leukemia 2015 ·Leukemia ·(unknown), Christian Thiede, Tilmann Bochtler, Jürgen G. Okun, (unknown), Axel Benner, Stefan Pusch, Gerhard Ehninger, Markus Schaich, Anthony D. Ho, Andreas von Deimling, Andrea Krämer, Christoph E. Heilig	19
17	Clonal Heterogeneity As Detected by Metaphase Karyotyping Is an Indicator of Poor Prognosis in Acute Myeloid Leukemia 2013 ·Journal of Clinical Oncology ·Tilmann Bochtler, Friedrich Stölzel, Christoph E. Heilig, Christina Kunz, Brigitte Mohr, Anna Jauch, Johannes W.G. Janssen, Michael Krämer, Axel Benner, Martin Bornhäuser, Anthony D. Ho, Gerhard Ehninger, Markus Schaich, Alwin Krämer	51
18	Chromosomal instability correlates with poor outcome in patients with myelodysplastic syndromes irrespectively of the cytogenetic risk group 2009 ·Journal of Cellular and Molecular Medicine ·Christoph E. Heilig, H. Löffler, Ulrich Mahlknecht, Johannes W.G. Janssen, Anthony D. Ho, Anna Jauch, Alwin Krämer	48
19	Microcephalin and pericentrin regulate mitotic entry via centrosome-associated Chk1 2009 ·The Journal of Cell Biology ·(unknown), Joachim Marhold, Hanswalter Zentgraf, Christoph E. Heilig, Heidemarie Neitzel, Bernard Ducommun, Anita Rauch, Anthony D. Ho, Jiří Bártek, Alwin Krämer	74
20	Immunogenicity, efficacy and adverse events of adalimumab in RA patients 2006 ·Rheumatology International ·(unknown), Christoph E. Heilig, (unknown), Jessica Wohlgemuth, (unknown), Bernhard Heilig	113

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact